References
- Aoyama H, Tabata N, Tanaka M, et al. (1995). Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br J Dermatol 133:494–6
- Ashcroft DM, Dimmock P, Garside R, et al. (2005). Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. Br Med J 330:516–22
- Boguniewicz M, Fiedler VC, Raimer S, et al. (1998). A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 102:637–44
- Boukamp P, Petrussevska RT, Breitkreutz D, et al. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–71
- Carr WW. (2013). Topical calcineurin inhibitors for atopic dermatitis: Review and treatment recommendations. Paediatr Drugs 15:303–10
- Fukuyama T, Tajima Y, Hayashi K, et al. (2011). Prior or coinstantaneous oral exposure to environmental immunosuppressive agents aggravates mite allergen-induced atopic dermatitis-like immunoreaction in Nc/Nga mice. Toxicology 289:132–40
- Hanifin JM, Cooper KD, Ho VC, et al. (2004). Guidelines of care for atopic dermatitis. J Am Acad Dermatol 50:391–404
- Kao TH, Huang CW, Chen BH. (2012). Functional components in Luffa cylindrica and their effects on anti-inflammation of macrophage cells. Food Chem 135:386–95
- Khajuria A, Gupta A, Garai S, Wakhloo BP. (2007). Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrical in Balb/C mice. Bioorg Med Chem Lett 17:1608–12
- Lee H, Lee JK, Ha H, et al. (2012). Angelicae Dahuricae Radix inhibits dust mite extract-induced atopic dermatitis-like skin lesions in Nc/Nga mice. Evid Based Complem Alternat Med 2012:743075
- Leung DY. (1995). Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 96:302–18
- Liu FT, Goodarzi H, Chen HY. (2011). IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 41:298–310
- Liu L, Wang R, He W, et al. (2010). Cloning and soluble expression of mature alpha-luffin from Luffa cylindrica and its antitumor activities in vitro. Acta Biochim Biophys Sin (Shanghai) 42:585–92
- Nakazawa M, Sugi N, Kawaguchi H, et al. (1997). Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 99:673–82
- Ng YM, Yang Y, Sze KH, et al. (2011). Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica). J Struct Biol 174:164–72
- Pastore S, Mascia F, Girolomoni G. (2006). The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 16:12–31
- Ring J, Alomar A, Bieber T, et al. (2012a). Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J Eur Acad Dermatol Venereol 26:1045–60
- Ring J, Alomar A, Bieber T, et al. (2012b). Guidelines for treatment of atopic eczema (atopic dermatitis). Part II. J Eur Acad Dermatol Venereol 26:1176–93
- Tanaka S, Uno C, Akimoto M, et al. (1991). Anti-allergic effect of bryonolic acid from Luffa cylindrica cell suspension cultures. Planta Med 57:527–30
- Terui T. (2009). Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: Overview of the pathophysiology of atopic dermatitis. J Pharmacol Sci 110:232–6
- Tomi NS, Luger TA. (2003). The treatment of atopic dermatitis with topical immunomodulators. Clin Dermatol 21:215–24